Please wait while the formulary information is being retrieved.
SINUS 12-HOUR (PSEUDOEPHEDRINE HCL)
- Nasal congestion
- Wal-phed D Tablet,extended Release
- Wal-phed 12 Hour Tablet,extended Release
- Suphedrine 12 Hour Tablet,extended Release
- Sudogest 12-hour Tablet,extended Release
- Sudafed 12 Hour Tablet,extended Release
- Sinus 12 Hour Tablet,extended Release
- Pseudoephedrine Er Tablet,extended Release
- Nasal Decongestant Er Tablet,extended Release
- Nasal Decongestant (pseudoephedrine) Tablet,extended Release
- Long Acting Nasal Decongestant (pse) Tablet,extended Release
- 12 Hour Nasal Decongestant (pse) Tablet,extended Release
- 12 Hour Decongestant Er Tablet,extended Release
- By Indication
120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
Suphedrine 12 Hour 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
12-hour 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
Sudafed 12 Hour 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
Sinus 12 Hour 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
(pseudoephedrine) 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
(pseudoephedrine) 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
(PSE) 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
(PSE) 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
12 Hour Nasal Decongestant (PSE) 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
ER 120 mg tablet,extended release
- 1 tablet (120 mg) by oral route every 12 hours
Nasal congestion
- 1 tablet (120 mg) by oral route every 12 hours
- 1 tablet (120 mg) by oral route every 12 hours as needed
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- Azilect
- bromocriptine
- cabergoline
- Cafergot
- Cycloset
- D.h.e.45
- dihydroergotamine
- Eldepryl
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- linezolid
- methylergonovine
- Migergot
- Migranal
- Parlodel
- rasagiline
- selegiline HCl
- Zelapar
- Zyvox
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- Angle-closure glaucoma
- Severe coronary artery disease
- Severe uncontrolled hypertension
- Urinary retention
Contraindicated
- Benign prostatic hyperplasia
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
Severe
Moderate
- None
SINUS 12-HOUR (PSEUDOEPHEDRINE HCL)
- Nasal congestion
- None
- Headache disorder
- Insomnia
More Frequent
Severe
Less Severe
- None
- Agitation
- Anorexia
- Dizziness
- Drowsy
- Dysuria
- General weakness
- Nausea
- Nervousness
- Pallor
- Tachycardia
- Tremor
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute generalized exanthematous pustulosis
- Dyspnea
- Hallucinations
- Hypertension
- Ischemic colitis
- Seizure disorder
- Vomiting
Less Severe
- Abdominal pain with cramps
- Cardiac arrhythmia
- Dyspepsia
- Excitement
- Hyperhidrosis
- Palpitations
- Symptoms of anxiety
Contraindicated
Pseudoephedrine (SR or High Dose)
Increased sensitivity to side effects. Dose form or strength not appropriate.
- 1 Day – 12 Years
- 1 Increased sensitivity to side effects. Dose form or strength not appropriate.
Severe Precaution
None
Management or Monitoring Precaution
None
Pseudoephedrine
- Severity Level:
C
- Additional Notes: Fda c w/combo prod; poss risk of gastroschisis/sia with 1st trimester exposure
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Pseudoephedrine
May decrease milk supply, and cause irritability
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Drug shown to have adverse effect | May decrease milk supply, and cause irritability |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Nasal congestion | |
| R09.81 | Nasal congestion |
| 0-9 | A-Z |
|---|---|
| R09.81 | Nasal congestion |
Formulary Reference Tool